Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of dosing frequency on chronic cardiovascular disease medication adherence
Craig I Coleman, Matthew Roberts, Diana M Sobieraj, et al.
Current Medical Research and Opinion (2012) Vol. 28, Iss. 5, pp. 669-680
Closed Access | Times Cited: 121

Showing 26-50 of 121 citing articles:

Ensuring medication adherence with direct oral anticoagulant drugs
Alessandro Di Minno, Gaia Spadarella, Antonella Tufano, et al.
Thrombosis Research (2014) Vol. 133, Iss. 5, pp. 699-704
Closed Access | Times Cited: 40
New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents
Marta Boffito, Akil Jackson, Andrew Owen, et al.
Drugs (2013) Vol. 74, Iss. 1, pp. 7-13
Closed Access | Times Cited: 39
A Retrospective Descriptive Analysis of Patient Adherence to Dabigatran at a Large Academic Medical Center
Timothy Cutler, Alan Chuang, Tony Huynh, et al.
Journal of Managed Care Pharmacy (2014) Vol. 20, Iss. 10, pp. 1028-1034
Open Access | Times Cited: 39
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy
Craig I Coleman, Sylvia Haas, Alexander G.G. Turpie, et al.
Clinical Cardiology (2016) Vol. 39, Iss. 10, pp. 565-569
Open Access | Times Cited: 37
Impacto da frequência posológica na adesão terapêutica em doenças cardiovasculares crónicas: revisão sistemática e meta‐análise
Daniel Caldeira, António Vaz Carneiro, João Costa
Revista Portuguesa de Cardiologia (2014) Vol. 33, Iss. 7-8, pp. 431-437
Open Access | Times Cited: 36
The impact of dosing frequency on medication adherence in chronic cardiovascular disease: Systematic review and meta-analysis
Daniel Caldeira, António Vaz Carneiro, João Costa
Revista Portuguesa de Cardiologia (English Edition) (2014) Vol. 33, Iss. 7-8, pp. 431-437
Open Access | Times Cited: 36
Factors Influencing Oral Adherence: Qualitative Metasummary and Triangulation With Quantitative Evidence
Leigh Johnson
Clinical journal of oncology nursing (2015) Vol. 19, Iss. 3, pp. 6-30
Closed Access | Times Cited: 36
Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation
Winnie W. Nelson, Xue Song, Erin Thomson, et al.
Current Medical Research and Opinion (2015) Vol. 31, Iss. 10, pp. 1831-1840
Closed Access | Times Cited: 34
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake
Emilie R Elliot, Alieu Amara, Akil Jackson, et al.
Journal of Antimicrobial Chemotherapy (2015) Vol. 71, Iss. 4, pp. 1031-1036
Open Access | Times Cited: 34
Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States
Craig I Coleman, Muralikrishna Tangirala, Thomas Evers
International Journal of Cardiology (2016) Vol. 212, pp. 171-173
Closed Access | Times Cited: 34
Patient Satisfaction with Direct Oral Anticoagulants and Warfarin
Yasuo Okumura, Katsuaki Yokoyama, Naoya Matsumoto, et al.
International Heart Journal (2018) Vol. 59, Iss. 6, pp. 1266-1274
Open Access | Times Cited: 33
Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience
Leon A. Simons, Michael Ortiz, Ben Freedman, et al.
Current Medical Research and Opinion (2016) Vol. 32, Iss. 11, pp. 1857-1861
Closed Access | Times Cited: 32
Adherence and persistence with direct oral anticoagulants by dose regimen: A systematic review
Raúl Quirós López, Francesç Formiga, Jan Beyer‐Westendorf
British Journal of Clinical Pharmacology (2025)
Open Access
Adherence to Pharmacotherapy for Secondary Prevention of Coronary Heart Disease: A Registry-Based Prospective Study
Aradhai Bana, Krishna Kumar Sharma, Soneil Guptha, et al.
Indian Heart Journal (2025)
Open Access
Medication adherence part two: Predictors of nonadherence and adherence
Kathy J. Wheeler, Mary Ellen Roberts, Mary B. Neiheisel
Journal of the American Association of Nurse Practitioners (2014) Vol. 26, Iss. 4, pp. 225-232
Closed Access | Times Cited: 30
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk
Melvin Lafeber, Wilko Spiering, Frank L.J. Visseren, et al.
European Journal of Preventive Cardiology (2017) Vol. 24, Iss. 9, pp. 951-961
Closed Access | Times Cited: 29
Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation
Tsuyoshi Suzuki, Tsuyoshi Shiga, Hisako Omori, et al.
Journal of Cardiology (2016) Vol. 70, Iss. 3, pp. 238-243
Open Access | Times Cited: 27
Exploring variables associated with medication non-adherence in patients with type 2 diabetes mellitus
Walid Al‐Qerem, Anan S. Jarab, Mohammad Badinjki, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0256666-e0256666
Open Access | Times Cited: 23
A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban
Reinhold Kreutz
Journal of Thrombosis and Thrombolysis (2013) Vol. 38, Iss. 2, pp. 137-149
Closed Access | Times Cited: 29
Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation
Walter Ageno, Jan Beyer‐Westendorf, Andrea Rubboli
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 13, pp. 1325-1332
Closed Access | Times Cited: 26
Direct Oral Anticoagulants for the Management of Thromboembolic Disorders
Alpesh Amin, Joel C. Marrs
Clinical and Applied Thrombosis/Hemostasis (2015) Vol. 22, Iss. 7, pp. 605-616
Open Access | Times Cited: 25
The new oral anticoagulants in atrial fibrillation: Once daily or twice daily?
Giulia Renda, Raffaele De Caterina
Vascular Pharmacology (2013) Vol. 59, Iss. 3-4, pp. 53-62
Closed Access | Times Cited: 26
Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis‐mediated conditions
Troy C. Sarich, Gary Peters, Scott D. Berkowitz, et al.
Annals of the New York Academy of Sciences (2013) Vol. 1291, Iss. 1, pp. 42-55
Closed Access | Times Cited: 23
Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation
Bilqees Fatima, Anjana Mohan, Issra Altaie, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 5, pp. 408-419
Open Access | Times Cited: 2
Relevance of dosage in adherence to treatment with long-acting anticholinergics in patients with COPD
José Luís Izquierdo Alonso, José Manuel Paredero, Raul Piedra
International Journal of COPD (2016), pp. 289-289
Open Access | Times Cited: 19

Scroll to top